Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries
-
Pisana, Alice (Karolinska Institutet (Estocolm, Suècia))
;
Wettermark, Björn (Vilnius University) ;
Kurdi, Amanj (Sefako Makgatho Health Sciences University) ;
Tubic, Biljana (University of Banja Luka) ;
Pontes García, Caridad (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ;
Zara, Corinne (Servei Català de la Salut) ;
Van Ganse, Eric (Croix Rousse University Hospital (Lyon, França)) ;
Petrova, Guenka (PharmacoEpidemiology Lyon) ;
Mardare, Ileana ("Carol Davila" University of Medicine and Pharmacy Bucharest (Bucarest, Rumania)) ;
Fürst, Jurij (Health Insurance Institute) ;
Roig-Izquierdo, Marta (Servei Català de la Salut) ;
Melien, Oyvind (Oslo University Hospital (Oslo, Noruega)) ;
Bonanno, Patricia Vella (University of Malta) ;
Banzi, Rita (Istituto di Ricerche Farmacologiche Mario Negri IRCCS) ;
Marković-Peković, Vanda (University of Banja Luka) ;
Mitkova, Zornitsa (PharmacoEpidemiology Lyon) ;
Godman, Brian (Ajman University)
Subscribe to this discussion. You will then receive all new comments by email.
guest ::
